• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两名急性白血病患者在输注两性霉素B脂质体期间出现肺部毒性。

Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia.

作者信息

Arning M, Heer-Sonderhoff A H, Wehmeier A, Schneider W

机构信息

Heinrich-Heine-University Medical Center, Department of Haematology, Oncology and Clinical Immunology, Düsseldorf, Germany.

出版信息

Eur J Clin Microbiol Infect Dis. 1995 Jan;14(1):41-3. doi: 10.1007/BF02112616.

DOI:10.1007/BF02112616
PMID:7729451
Abstract

Pulmonary toxicity with acute dyspnea occurred during infusion of a liposomal amphotericin B preparation (AmBisome) in two adult leukemic patients. The preparation was administered as a one hour infusion at a dose of 3 mg/kg body weight. Within 15 min after starting the infusion, both patients experienced sudden onset of dyspnea and chest tightness. Physical examination showed the patients to be anxious and restless with tachycardia and orthopnea but without other cardiopulmonary findings. No elevation of body temperature, rigors or chills were recorded. Symptoms disappeared within minutes after discontinuing the infusion. At present, the pathophysiologic mechanisms underlying these side effects are unknown.

摘要

两名成年白血病患者在输注脂质体两性霉素B制剂(安必素)期间出现伴有急性呼吸困难的肺部毒性。该制剂以3mg/kg体重的剂量进行1小时输注给药。在开始输注后15分钟内,两名患者均突然出现呼吸困难和胸闷。体格检查显示患者焦虑不安,有心动过速和端坐呼吸,但无其他心肺方面的表现。未记录到体温升高、寒战或发冷。停止输注后数分钟内症状消失。目前,这些副作用潜在的病理生理机制尚不清楚。

相似文献

1
Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia.两名急性白血病患者在输注两性霉素B脂质体期间出现肺部毒性。
Eur J Clin Microbiol Infect Dis. 1995 Jan;14(1):41-3. doi: 10.1007/BF02112616.
2
Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature.
Pharmacotherapy. 1998 Sep-Oct;18(5):1053-61.
3
Amphotericin B--not so terrible.两性霉素B——没那么可怕。
Ann Pharmacother. 2001 Mar;35(3):308-10. doi: 10.1345/aph.10240.
4
Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels.三种不同两性霉素B制剂的输液相关毒性及其与细胞因子血浆水平的关系。
Mycoses. 1995 Nov-Dec;38(11-12):459-65. doi: 10.1111/j.1439-0507.1995.tb00020.x.
5
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.脂质体两性霉素B用于持续发热和中性粒细胞减少患者的经验性治疗。美国国立过敏和传染病研究所真菌病研究组。
N Engl J Med. 1999 Mar 11;340(10):764-71. doi: 10.1056/NEJM199903113401004.
6
Cardiopulmonary toxicity after liposomal amphotericin B infusion.脂质体两性霉素B输注后的心肺毒性。
Ann Intern Med. 1991 Apr 15;114(8):664-6. doi: 10.7326/0003-4819-114-8-664.
7
Pharmacokinetics and tolerance of liposomal amphotericin B in patients.脂质体两性霉素B在患者体内的药代动力学和耐受性
J Antimicrob Chemother. 1993 Jul;32(1):133-9. doi: 10.1093/jac/32.1.133.
8
Amphotericin B toxicity reduced by administration in fat emulsion.
Ann Pharmacother. 1995 May;29(5):496-500. doi: 10.1177/106002809502900509.
9
[Acute adverse effects following administration of liposomal amphotericin B].[脂质体两性霉素B给药后的急性不良反应]
Enferm Infecc Microbiol Clin. 2006 May;24(5):352. doi: 10.1157/13089673.
10
[Liposomal amphotericin B in the treatment of candida infection in a 3-month-old infant].[脂质体两性霉素B治疗3个月大婴儿念珠菌感染]
Padiatr Padol. 1992;27(4):97-9.

引用本文的文献

1
Preparation and In Vitro Evaluation of Alginate Microparticles Containing Amphotericin B for the Treatment of Infections.含两性霉素B的藻酸盐微粒用于治疗感染的制备及体外评价
Int J Biomater. 2020 Aug 1;2020:2514387. doi: 10.1155/2020/2514387. eCollection 2020.
2
Immunological and Toxicological Considerations for the Design of Liposomes.脂质体设计的免疫学和毒理学考量
Nanomaterials (Basel). 2020 Jan 22;10(2):190. doi: 10.3390/nano10020190.
3
Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.

本文引用的文献

1
Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.脂质体两性霉素B(安必素)预防真菌感染:一项针对骨髓移植受者的随机试验
Transplant Proc. 1993 Feb;25(1 Pt 2):1495-7.
2
Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep.
J Appl Physiol (1985). 1988 Mar;64(3):1143-52. doi: 10.1152/jappl.1988.64.3.1143.
3
Effect of infusion rate on amphotericin B-associated febrile reactions.
Drug Intell Clin Pharm. 1988 Oct;22(10):769-72. doi: 10.1177/106002808802201005.
4
浸润性肺部疾病:血液系统恶性肿瘤患者使用新型抗肿瘤药物的并发症
Can Respir J. 2008 May-Jun;15(4):211-6. doi: 10.1155/2008/305234.
4
Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.两性霉素B小单层脂质体制剂(安必素)在中性粒细胞减少患者中的安全性、耐受性及药代动力学
Antimicrob Agents Chemother. 1998 Sep;42(9):2391-8. doi: 10.1128/AAC.42.9.2391.
5
Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.5%葡萄糖溶液或20%脂肪乳剂中两性霉素B在中性粒细胞减少的肺炎或不明原因发热患者中的安全性和毒性:随机研究
BMJ. 1998 Aug 8;317(7155):379-84. doi: 10.1136/bmj.317.7155.379.
6
Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.脂质体两性霉素B。在真菌感染和内脏利什曼病治疗中的应用。
Drugs. 1998 Apr;55(4):585-612. doi: 10.2165/00003495-199855040-00008.
7
Antifungal agents in the 1990s. Current status and future developments.20世纪90年代的抗真菌药物。现状与未来发展。
Drugs. 1997 Apr;53(4):539-49. doi: 10.2165/00003495-199753040-00001.
Cardiopulmonary toxicity after liposomal amphotericin B infusion.脂质体两性霉素B输注后的心肺毒性。
Ann Intern Med. 1991 Apr 15;114(8):664-6. doi: 10.7326/0003-4819-114-8-664.
5
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial.脂质体两性霉素B(安必素):一项II/III期临床试验的安全性数据。
J Antimicrob Chemother. 1991 Oct;28 Suppl B:83-91. doi: 10.1093/jac/28.suppl_b.83.